Impairment of endothelium-dependent vasorelaxation in cadmium-hypertensive rats

Toxicology and Industrial Health

Volumn 25, Issue 7, 2009, Pages 447-453

  Gokalp O ^a   Ozdem S ^b   Donmez S ^c   Dogan, M ^c   Demirin, H ^c   Kara, Y ^c   Sutcu R ^c   Cicek, E ^c   Özer, Mk ^c   Delibas, N ^c  

^a DICLE UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

^c SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

acetylcholine; cadmium; hypertension; malondialdehyde; nitric oxide

Indexed keywords

ACETYLCHOLINE; CADMIUM CHLORIDE; ENDOTHELIUM DERIVED RELAXING FACTOR; MALONALDEHYDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; HYPERTENSION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; THORACIC AORTA;

ACETYLCHOLINE; ANIMALS; ARGININE; CADMIUM; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; MALONDIALDEHYDE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; RATS; VASODILATION;

ANIMALIA; RATTUS;

EID: 70349479414     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233709106822     Document Type: Article

References (37)

1. Bilgen, I., Oner, G., Edremitlioglu, M., Alkan, Z., Cirrik, S. (2003) Involvement of cholinoceptors in cadmium-induced endothelial dysfunction. J Basic Clin Physiol Pharmacol 14: 55-76.
2. Cavicchi, M., Gibbs, L., Whittle, BJ (2000) Inhibition of inducible nitric oxide synthase in the human intestinal epithelial cell line, DLD-1, by the inducers of heme oxygenase 1, bismuth salts, heme, and nitric oxide donors. Gut 47: 771-778.
3. Demontis, MP, Varoni, MV, Volpe, AR, Emanueli, C., Madeddu, P. (1998) Role of nitric oxide synthase inhibition in the acute hypertensive response to intracerebroventricular cadmium. Br J Pharmacol 123: 129-135.
4. Draper, HH, Hadley, M. (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186: 421-431.
5. Fadloun, Z., Leach, GD (1981) The effects of cadmium ions on blood pressure, dopamine-beta-hydroxylase activity and on the responsiveness of in vivo preparations to sympathetic nerve stimulation, noradrenaline and tyramine. J Pharm Pharmacol 33: 660-664.
6. Gibbons, GH, Dzau, VJ (1994) The emerging concept of vascular remodeling. N Eng J Med 330: 1431-1438. (Review).
7. Glauser, SC, Bello, CT, Glauser, EM (1976) Blood-cadmium levels in normotensive and untreated hypertensive humans. Lancet 1: 717-718.
8. Hayakawa, H., Coffee, K., Raij, L. (1997a) Endothelial dysfunction and cardio-renal injury in experimental salt sensitive hypertension effects of antihypertensive therapy. Circulation 96: 2407-2413.
9. Hayakawa, H., Raij, L. (1997b) The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertrophy. Hypertension 29: 235-241.
10. Hayakawa, H., Rag, L. (1998) Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 31(Part 2): 266-270.
11. Hussain, T., Shukla, GS, Chandra, SV (1987) Effects of cadmium on superoxide dismutase and lipid peroxidation in liver and kidney of growing rats: in vivo and in vitro studies. Pharmacol Toxicol 60: 355-358.
12. Kaizu, K., Uriu, K. (1995) Tubulointerstitial injuries in heavy metal intoxications. Nippon Rinsho 53: 2052-2056.
13. Karabulut-Bulan, O., Bolkent, S., Yanardag, R., Bilgin-Sokmen, B. (2008) The role of vitamin C, vitamin E, and selenium on cadmium-induced renal toxicity of rats. Drug Chem Toxicol 31: 413-426.
14. Kutzman, RS, Drew, RT, Shiotsuka, RN, Cockrell, BY (1986) Pulmonary changes resulting from subchronic exposure to cadmium chloride aerosol. J Toxicol Environ Health 17: 175-189.
15. Lener, J., Bibr, B. (1971) Cadmium and hypertension. Lancet 297: 970.
16. Lowry, OH, Rosebrough, NJ, Farr, AL, Randall, RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
17. Manca, D., Ricard, AC, Trottier, B., Chevalier, G. (1991) Studies on lipid peroxidation in rat tissues following administration of low and moderate doses of cadmium chloride. Toxicology 67: 303-323.
18. Mollaoglu, H., Gokcimen, A., Ozguner, F., Oktem, F., Koyu, A., Kocak, A., et al. (2006) Caffeic acid phenethyl ester prevents cadmium-induced cardiac impairment in rat. Toxicology 227: 15-20. (Epub 2006 Jul 13).
19. Moshage, H., Kok, B., Huizenga, JR, Jansen, PLM (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 41: 892-896.
20. Osman, K., Schutz, A., Akesson, B., Maciag, A., Vahter, M. (1998) Interactions between essential and toxic elements in lead exposed children in Katowice, Poland. Clin Biochem 31: 657-665.
21. Ozdem, SS, Oğütman, C. (1997) Responsiveness of aortic rings of cadmium-hypertensive rats to endothelin-1. Pharmacology 54: 328-332.
22. Ozdem, SS, Oğütman, C. (1999) The effects of short-term nifedipine treatment on responsiveness of aortic rings of cadmium-hypertensive rats. Clin Exp Hypertens 21: 423-440.
23. Poliandri, AH, Esquifino, AI, Cano, P., Jimenez, V., Lafuente, A., Cardinali, DP, et al. (2006) In vivo protective effect of melatonin on cadmium-induced changes in redox balance and gene expression in rat hypothalamus and anterior pituitary. J Pineal Res 41: 238-246.
24. Puri, VN (1999) Cadmium induced hypertension. Clin Exp Hypertens 21: 79-84.
25. Puri, VN, Sur, RN (1983) Cardiovascular effects of cadmium on intravenous and intracerebroventricular administration in rats. Can J Physiol Pharmacol 61: 1430-1432.
26. Reddy, KB, Yee, D., Hilsenbeck, SG, Coffey, RJ, Osborne, CK (1994) Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression. Cell Growth Differ 5: 1275-1282.
27. Rencuzogullari, N., Erdoğan, S. (2007) Oral Administration of Lycopene Reverses Cadmium-suppressed Body Weight Loss and Lipid Peroxidation in Rats. Biol Tr El Res 118: 175-183.
28. Salter, M., Knolls, RAG, Moncada, S. (1991) Widespread tissue distribution, species distribution and changes in activity of Ca2+-dependent and Ca2+-independent nitric oxide synthases. FEBS Lett 291: 145-149.
29. Satarug, S., Baker, JR, Urbenjapol, S., Haswell-Elkins, M., Reilly, PE, Williams, DJ, et al. (2003) A global perspective on cadmium pollution and toxicity in nonoccupationally exposed population. Toxicol Lett 137: 65-83.
30. Sato, M., Kondoh, M. (2002) Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med 196: 9-22.
31. Schiffrin, EL (2002) Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 15: 115S-122S.
32. Skoczynska, A., Martynowicz, H. (2005) The impact of subchronic cadmium poisoning on the vascular effect of nitric oxide in rats. Hum Exp Toxicol 24: 353-361.
33. Sutoo, D., Akiyama, K. (1997) Regulation of blood pressure with calcium-dependent dopamine synthesizing system in the brain and its related phenomena. Brain Res Rev 25: 1-26.
34. Szuster-Ciesielska, A., Stachura, A., Slotwinska, M., Kaminska, T., Sniezko, R., Paduch, R., et al. (2000) The inhibitory effect of zinc on cadmium-induced cell apoptosis and reactive oxygen species (ROS) production in cell cultures. Toxicology 145: 159-171.
35. Touyz, RM (2003) Role of magnesium in the pathogenesis of hypertension. Mol Aspects Med 24: 107-136.
36. WHO/IPCS (1992) Environmental Health Criteria Document 134 Cadmium. Geneva: WHO.
37. Wittman, R., Hu, H. (2002) Cadmium exposure and nephropathy in a 28-year-old female metals worker. Environ Health Perspect 110: 1261-1266.